Physician profile
Deidre Pagan
NPI 1740390103
$1,776.98
in general payments reported to CMS, 2019-2025
8 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $248 · 2023: $456 · 2024: $103 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761 · Education: $220 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $761.17 |
| Education | $219.97 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $661.46 | 2021-2025 | |
| Harmony Biosciences LLC | $479.34 | 2021-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $251.35 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $201.99 | 2025 | Sunosi |
| Eisai INC. | $137.03 | 2021 | |
| Idorsia Pharmaceuticals US INC | $18.55 | 2024 | Quviviq |
| Arbor Pharmaceuticals, INC. | $14.97 | 2021 | |
| Philips North America LLC | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deidre Pagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.